Trends of COVID-19 incidence in Manitoba and public health measures: March 2020 to February 2022.
COVID-19
Incidence
Masks
Mitigation measures
Physical distancing
Journal
BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768
Informations de publication
Date de publication:
10 May 2022
10 May 2022
Historique:
received:
31
01
2022
accepted:
24
04
2022
entrez:
10
5
2022
pubmed:
11
5
2022
medline:
14
5
2022
Statut:
epublish
Résumé
The increasing spread of severe acute respiratory syndrome coronavirus-2 has prompted Canada to take unprecedented measures. The objective of this study was to examine the impact of the implemented public health measures on the incidence of COVID-19 in Manitoba. Using the COVID-19 dataset, we examined the temporal trends of daily reported COVID-19 cases and the coinciding public health measures implemented from March 12, 2020 to February 28, 2022. We calculated the 7-day moving average and crude COVID-19 infection rate/100,000 Manitobans. Due to the restrictions applied, the infection rate decreased from 2.4 (April 1) to 0.07 infections (May 1, 2020). Between May 4 and July 17, 2020, the reported cases stabilized, and some restrictions were lifted. However, in November, the cases peaked with infection rate of 29. Additional restrictions were implemented, and the rate dropped to 3.6 infections on March 31, 2021. As of August 2021, 62.8% of eligible Manitobans received two vaccine doses. The infection rate increased to 128.3 infections on December 31, 2021 and mitigation measures were implemented. This study describes how physical distancing in conjunction with other containment measures can reduce the COVID-19 burden. Future studies into the extent of the implementation of the restrictions are necessary.
Identifiants
pubmed: 35538498
doi: 10.1186/s13104-022-06049-5
pii: 10.1186/s13104-022-06049-5
pmc: PMC9088149
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
162Subventions
Organisme : Research Manitoba
ID : #4443
Informations de copyright
© 2022. The Author(s).
Références
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
MMWR Morb Mortal Wkly Rep. 2020 Dec 11;69(49):1860-1867
pubmed: 33301434
N Engl J Med. 2022 Mar 10;386(10):933-941
pubmed: 35020982
Int J Infect Dis. 2020 Apr;93:211-216
pubmed: 32145465
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093
pubmed: 34383730
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1460-1463
pubmed: 33031366
Saf Sci. 2020 Aug;128:104773
pubmed: 32296266